Clinical Trial Update: Vitrectomy and Bevacizumab for Diffuse Diabetic Macular Edema [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the combination of vitrectomy and bevacizumab for diffuse diabetic macular edema has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Macular Edema

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: Asociación para Evitar la Ceguera en México | Conditions: Diffuse Diabetic Macular Edema | Phase 3 | Status: TERMINATED